153 related articles for article (PubMed ID: 21726543)
1. Dimethoxycurcumin, a metabolically stable analogue of curcumin, exhibits anti-inflammatory activities in murine and human lymphocytes.
Patwardhan RS; Checker R; Sharma D; Kohli V; Priyadarsini KI; Sandur SK
Biochem Pharmacol; 2011 Sep; 82(6):642-57. PubMed ID: 21726543
[TBL] [Abstract][Full Text] [Related]
2. Differential antioxidant/pro-oxidant activity of dimethoxycurcumin, a synthetic analogue of curcumin.
Kunwar A; Barik A; Sandur SK; Indira Priyadarsini K
Free Radic Res; 2011 Aug; 45(8):959-65. PubMed ID: 21615275
[TBL] [Abstract][Full Text] [Related]
3. Curcumin and its synthetic analogue dimethoxycurcumin differentially modulates antioxidant status of normal human peripheral blood mononuclear cells.
Simon E; Aswini P; Sameer Kumar VB; Mankadath G
Free Radic Res; 2018 May; 52(5):583-591. PubMed ID: 29621898
[TBL] [Abstract][Full Text] [Related]
4. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis.
Kunwar A; Jayakumar S; Srivastava AK; Priyadarsini KI
Arch Toxicol; 2012 Apr; 86(4):603-14. PubMed ID: 22119759
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
6. Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS.
Pae HO; Jeong SO; Kim HS; Kim SH; Song YS; Kim SK; Chai KY; Chung HT
Mol Nutr Food Res; 2008 Sep; 52(9):1082-91. PubMed ID: 18481332
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
Gao X; Kuo J; Jiang H; Deeb D; Liu Y; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Biochem Pharmacol; 2004 Jul; 68(1):51-61. PubMed ID: 15183117
[TBL] [Abstract][Full Text] [Related]
8. Biological and pharmacological evaluation of dimethoxycurcumin: A metabolically stable curcumin analogue with a promising therapeutic potential.
Teymouri M; Barati N; Pirro M; Sahebkar A
J Cell Physiol; 2018 Jan; 233(1):124-140. PubMed ID: 27996095
[TBL] [Abstract][Full Text] [Related]
9. Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonyl-anthranilic acid (tranilast) is mediated by CXCL9 and CXCL10.
Hertenstein A; Schumacher T; Litzenburger U; Opitz CA; Falk CS; Serafini T; Wick W; Platten M
Biochem Pharmacol; 2011 Sep; 82(6):632-41. PubMed ID: 21703247
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin.
Tamvakopoulos C; Dimas K; Sofianos ZD; Hatziantoniou S; Han Z; Liu ZL; Wyche JH; Pantazis P
Clin Cancer Res; 2007 Feb; 13(4):1269-77. PubMed ID: 17317839
[TBL] [Abstract][Full Text] [Related]
11. Curcumin attenuates inflammatory response in IL-1beta-induced human synovial fibroblasts and collagen-induced arthritis in mouse model.
Moon DO; Kim MO; Choi YH; Park YM; Kim GY
Int Immunopharmacol; 2010 May; 10(5):605-10. PubMed ID: 20188213
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.
Ranjan D; Chen C; Johnston TD; Jeon H; Nagabhushan M
J Surg Res; 2004 Oct; 121(2):171-7. PubMed ID: 15501456
[TBL] [Abstract][Full Text] [Related]
13. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia.
Jin CY; Lee JD; Park C; Choi YH; Kim GY
Acta Pharmacol Sin; 2007 Oct; 28(10):1645-51. PubMed ID: 17883952
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages.
Kang BY; Song YJ; Kim KM; Choe YK; Hwang SY; Kim TS
Br J Pharmacol; 1999 Sep; 128(2):380-4. PubMed ID: 10510448
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo inhibition of activation induced T cell apoptosis by bucillamine.
Okazaki H; Sato H; Kamimura T; Hirata D; Iwamoto M; Yoshio T; Mimori A; Masuyama JI; Kano S; Minota S
J Rheumatol; 2000 Jun; 27(6):1358-64. PubMed ID: 10852254
[TBL] [Abstract][Full Text] [Related]
16. Liposomes encapsulated dimethyl curcumin regulates dipeptidyl peptidase I activity, gelatinase release and cell cycle of spleen lymphocytes in-vivo to attenuate collagen induced arthritis in rats.
Sun Z; Wei T; Zhou X
Int Immunopharmacol; 2018 Dec; 65():511-521. PubMed ID: 30408628
[TBL] [Abstract][Full Text] [Related]
17. Immune responses to novel allergens and modulation of inflammation by vitamin K3 analogue: a ROS dependent mechanism.
Kohli V; Sharma D; Sandur SK; Suryavanshi S; Sainis KB
Int Immunopharmacol; 2011 Feb; 11(2):233-43. PubMed ID: 21134493
[TBL] [Abstract][Full Text] [Related]
18. Interaction of a curcumin analogue dimethoxycurcumin with DNA.
Kunwar A; Simon E; Singh U; Chittela RK; Sharma D; Sandur SK; Priyadarsini IK
Chem Biol Drug Des; 2011 Apr; 77(4):281-7. PubMed ID: 21244640
[TBL] [Abstract][Full Text] [Related]
19. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
20. Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.
Dahlén R; Strid H; Lundgren A; Isaksson S; Raghavan S; Magnusson MK; Simrén M; Sjövall H; Öhman L
Scand J Immunol; 2013 Sep; 78(3):275-84. PubMed ID: 23713660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
